- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
March 7th, 2007
Nanoparticles - manufactured particles on the scale of atoms and molecules - are being developed to deliver drugs directly to cancer cells in the brain.
Right now, this system has been tested only on mice. Clinical trials involving people could begin within three years.
In order for most cancer drugs to be effective in the brain, they have to be administered in large doses. These toxic drugs kill the cancerous cells, but they also destroy healthy cells surrounding the tumor. Using nanotechnology, James Connor at Penn State University has devised a way to deliver smaller doses of drugs that target just cancerous cells using what's known as a "lipid-based nanoparticle."
|Related News Press|
Nanoparticle therapy that uses LDL and fish oil kills liver cancer cells February 9th, 2016
Leading bugs to the death chamber: A kinder face of cholesterol February 8th, 2016
UTHealth research looks at nanotechnology to help prevent preterm birth February 7th, 2016
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Scientists take nanoparticle snapshots February 10th, 2016
Chemical cages: New technique advances synthetic biology February 10th, 2016
Omni Nano and Time Warner Cable Partner to Provide Nanotechnology Education to the Boys & Girls Clubs of Los Angeles: A $10,000 Donation to Benefit Youth of Los Angeles County's Boys & Girls Clubs August 4th, 2015
Kalam: versatility personified August 1st, 2015